Sagamihara, Japan

Noriyuki Ota

This inventor holds 1 USPTO granted patent. Top assignee: Tosoh Corporation. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Ota. Retrieved from https://idiyas.com/inventor/noriyuki-ota-p6vd4u03

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriyuki Ota: Innovator in Pharmaceutical Composition Against AIDS

Introduction

Noriyuki Ota is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against AIDS. His innovative work has led to the development of a unique pharmaceutical composition that utilizes antibodies to target specific glycolipids.

Latest Patents

Ota holds a patent for a pharmaceutical composition against AIDS. This composition contains an active ingredient that is an antibody capable of recognizing glycolipid derived from Echinoidea. This innovative approach represents a promising avenue in the treatment of this devastating disease. He has 1 patent to his name.

Career Highlights

Noriyuki Ota is associated with Tosoh Corporation, where he has been able to apply his expertise in pharmaceutical research and development. His work at the company has been instrumental in advancing therapeutic options for patients suffering from AIDS.

Collaborations

Ota has collaborated with notable colleagues in his field, including Mitsuo Honda and Shudo Yamazaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Noriyuki Ota's contributions to pharmaceutical science, particularly in the development of treatments for AIDS, highlight his role as a key innovator in the industry. His work continues to inspire advancements in medical research and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…